Seizure: European Journal of Epilepsy
Volume 19, Issue 7 , Pages 443-445 , September 2010

Milder phenotype with SCN1A truncation mutation other than SMEI

Received 14 December 2009 ,Revised 9 June 2010 ,Accepted 17 June 2010.

References 

  1. Gambardella A, Marini C. Clinical spectrum of SCN1A mutations. Epilepsia. 2009;50(Suppl. 5):20–23
  2. Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, An-Gourfinkel I, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet. 2000;24:343–345
  3. Wallace RH, Scheffer IE, Barnett S, Richards M, Dibbens L, Desai RR, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2001;68:859–865
  4. Pineda-Trujillo N, Carrizosa J, Cornejo W, Arias W, Franco C, Cabrera D, et al. A novel SCN1A mutation associated with severe GEFS+ in a large South American pedigree. Seizure. 2005;14:123–128
  5. Wallace RH, Hodgson BL, Grinton BE, Gardiner RM, Robinson R, Rodriguez-Casero V, et al. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology. 2003;61:765–769
  6. Selmer KK, Lund C, Brandal K, Undlien DE, Brodtkorb E. SCN1A mutation screening in adult patients with Lennox–Gastaut syndrome features. Epilepsy Behav. 2009;16:555–557
  7. Meisler MH, Kearney JA. Sodium Channel mutations in epilepsy and other neurological disorders. J Clin Invest. 2005;115:2017–2018
  8. Singh R, Andermann E, Whitehouse WP, Harvey AS, Keene DL, Seni MH, et al. Severe myoclonic epilepsy of infancy: extended spectrum of GEFS +?. Epilepsia. 2001;42:837–844
  9. Sugawara T, Tsurubuchi Y, Fujiwara T, Mazaki-Miyazaki E, Nagata K, Montal M, et al. Nav1.1 channels with mutations of severe myoclonic epilepsy in infancy display attenuated currents. Epilepsy Res. 2003;54:201–207
  10. Liao W-P, Shi Y-W, Long Y-S, Zeng Y, Li T, Yu M-J, et al. Partial epilepsy with antecedent febrile seizures and seizure aggravation by antiepileptic drugs: associated with loss of function of Nav1.1. Epilepsia. 2010 Jun 7. [Epub ahead of print].
  11. Riva D, Vago C, Pantaleoni C, Bulgheroni S, Mantegazza M, Franceschetti S. Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes. Am J Med Genet A. 2009;149A:2339–2345
  12. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68:1327–1332
  13. Sugawara T, Mazaki-Miyazaki E, Fukushima K, Shimomura J, Fujiwara T, Hamano S, et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology. 2002;58:1122–1124
  14. Harkin LA, McMahon JM, Iona X, Dibbens L, Dibbens L, Pelekanos JT, et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain. 2007;130:843–852
  15. Gennaro E, Veggiotti P, Malacarne M, Madia F, Cecconi M, Cardinali S, et al. Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. Epileptic Disord. 2003;5:21–25
  16. Nakayama J, Arinami T. Molecular genetics of febrile seizures. Epilepsy Res. 2006;70(Suppl. 1):S190–S198
  17. Korff C, Laux L, Kelley K, Goldstein J, Koh S, Nordli D. Dravet syndrome (severe myoclonic epilepsy in infancy): a retrospective study of 16 patients. J Child Neurol. 2007;22:185–194
  18. Wakai S, Ito N, Sueoka H, Kawamoto Y, Hayasaka H, Chiba S. Severe myoclonic epilepsy in infancy and carbamazepine. Eur J Pediatr. 1996;155:724
  19. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 1998;39:508–512
  20. Saito Y, Oguni H, Awaya Y, Hayashi K, Osawa M. Phenytoin-induced choreoathetosis in patients with severe myoclonic epilepsy in infancy. Neuropediatrics. 2001;32:231–235
  21. Kröll-Seger J, Portilla P, Dulac O, Chiron C. Topiramate in the treatment of highly refractory patients with Dravet syndrome. Neuropediatrics. 2006;37:325–329
  22. Sankar R, Wheless JW, Dravet C, Guerrini R, Medina MT, Bureau M, et al. Treatment of myoclonic epilepsies in infancy and early childhood. Adv Neurol. 2005;95:289–298

PII: S1059-1311(10)00139-1

doi: 10.1016/j.seizure.2010.06.010

Seizure: European Journal of Epilepsy
Volume 19, Issue 7 , Pages 443-445 , September 2010

Article Tools

* Image Usage & Resolution